Link to this page
National Cancer Institute Thesaurus
Last uploaded:
February 23, 2024
Jump to:
| Preferred Name | Atenolol | |
| Synonyms |
ATENOLOL Atenolol |
|
| Definitions |
A synthetic isopropylamino-propanol derivative used as an antihypertensive, hypotensive and antiarrhythmic Atenolol acts as a peripheral, cardioselective beta blocker specific for beta-1 adrenergic receptors, without intrinsic sympathomimetic effects. It reduces exercise heart rates and delays atrioventricular conduction, with overall oxygen requirements decreasing. (NCI04) |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28836 |
|
| CAS_Registry |
29122-68-7
|
|
| CHEBI_ID |
CHEBI:2904
|
|
| Chemical_Formula |
C14H22N2O3
|
|
| code |
C28836
|
|
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C201600 |
|
| Contributing_Source |
CTRP FDA HemOnc
|
|
| DEFINITION |
A synthetic isopropylamino-propanol derivative used as an antihypertensive, hypotensive and antiarrhythmic Atenolol acts as a peripheral, cardioselective beta blocker specific for beta-1 adrenergic receptors, without intrinsic sympathomimetic effects. It reduces exercise heart rates and delays atrioventricular conduction, with overall oxygen requirements decreasing. (NCI04)
|
|
| Display_Name |
Atenolol
|
|
| FDA_UNII_Code |
50VV3VW0TI
|
|
| FULL_SYN |
ATENOLOL Atenolol
|
|
| Has_Target | ||
| label |
Atenolol
|
|
| Legacy Concept Name |
Atenolol
|
|
| NCI_Drug_Dictionary_ID |
590657
|
|
| PDQ_Closed_Trial_Search_ID |
590657
|
|
| PDQ_Open_Trial_Search_ID |
590657
|
|
| Preferred_Name |
Atenolol
|
|
| prefixIRI |
Thesaurus:C28836
|
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance
|
|
| UMLS_CUI |
C0004147
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping